Stockscreener 앱 받기
7.30
1.39%
0.10
Exozymes Inc 주식(EXOZ)의 최신 뉴스
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026 - ACCESS Newswire
eXoZymes to release 2025 results before March 31 investor call - Stock Titan
EXOZ Price Today: eXoZymes Inc. Stock Price, Quote & Chart - mexc.co
Whale Trades: Can eXoZymes Inc sustain earnings growthRate Hike & High Accuracy Investment Entry Signals - baoquankhu1.vn
eXoZymes (NASDAQ:EXOZ) Shares Up 2.4%What's Next? - MarketBeat
Momentum Shift: Is eXoZymes Inc forming a bullish divergenceForecast Cut & Reliable Price Action Trade Plans - baoquankhu1.vn
If You Invested $1,000 in eXoZymes Inc (EXOZ) - Stock Titan
Growth Recap: Whats the beta of eXoZymes Inc stock2026 Top Decliners & Long-Term Safe Return Strategies - baoquankhu1.vn
Aug PostEarnings: What is eXoZymes Incs market positionEarnings Risk Summary & Fast Moving Trade Plans - baoquankhu1.vn
Whale Trades: Will eXoZymes Inc benefit from seasonality2026 Analyst Calls & Technical Pattern Based Signals - baoquankhu1.vn
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability - ACCESS Newswire
Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability - SynBioBeta
Sell Signal: What are eXoZymes Incs recent SEC filings showing2026 Growth vs Value & Accurate Technical Buy Alerts - baoquankhu1.vn
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium - The National Law Review
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium - Bitget
The rare plant molecule eXoZymes is scaling for metabolic health - Stock Titan
Pullback Watch: Does eXoZymes Inc stock have upside surprise potentialJuly 2025 Rallies & Low Volatility Stock Recommendations - baoquankhu1.vn
Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS) - Defense World
Latest EXOZ NewseXoZymes Launches Subsidiary, NCTx, to Unlo... - Stock Titan
Molecular Partners (NASDAQ:MOLN) and eXoZymes (NASDAQ:EXOZ) Head-To-Head Analysis - Defense World
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value - EIN News
Is eXoZymes Inc backed by strong institutional buyingWeekly Profit Recap & Precise Trade Entry Recommendations - baoquankhu1.vn
Travel Stocks: Does eXoZymes Inc stock have upside surprise potentialJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Market Recap: Can Kearny Financial Corp withstand a market correctionJuly 2025 Sector Moves & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Algo Trading Space Launches Space Tracker: Advanced Trading Journal and Analytics Platform for VIP Members - MetroWest Daily News
Institution Moves: Is eXoZymes Inc a speculative investmentMarket Performance Report & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
EXOZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will eXoZymes Inc. stock continue upward momentumBond Market & Target Return Focused Picks - mfd.ru
Does eXoZymes Inc. stock reflect fundamentalsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru
Does eXoZymes Inc. stock have upside surprise potentialSell Signal & Weekly Top Gainers Alerts - mfd.ru
eXoZymes unveils new website and branding to reflect pharma focus By Investing.com - Investing.com South Africa
Quarterly Earnings: What chart patterns are forming on eXoZymes IncMarket Risk Analysis & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
eXoZymes unveils new website and branding to reflect pharma focus - Investing.com
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation - ACCESS Newswire
eXoZymes Reports Successful Pilot-Scale NCT Production Results - TipRanks
eXoZymes Inc Advances Commercial Readiness with NCT Pilot Run - TradingView
eXoZymes - Nasdaq
Critical Review: eXoZymes (NASDAQ:EXOZ) vs. Disc Medicine (NASDAQ:IRON) - Defense World
eXoZymes (NASDAQ:EXOZ) Trading Up 5.5%Here's Why - MarketBeat
Investment Report: Is eXoZymes Inc forming a bullish divergence2025 EndofYear Setup & Short-Term Trading Alerts - baoquankhu1.vn
Bond Watch: Will eXoZymes Inc benefit from current market trends2025 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Institution Moves: Can KMPR lead its sector in growthRisk Management & Community Consensus Trade Alerts - baoquankhu1.vn
eXoZymes Advances Commercial Readiness With Profound Production Metrics From Initial NCT Pilot Run - The National Law Review
Stock Recap: What is the long term forecast for ROIV stock2025 Momentum Check & Verified Swing Trading Watchlists - baoquankhu1.vn
Guidance Update: Can eXoZymes Inc sustain earnings growthJuly 2025 Closing Moves & Expert Curated Trade Ideas - baoquankhu1.vn
AI-enhanced enzymes yield pharma-grade NCT, ready for partner testing - Stock Titan
eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - galvnews.com
EXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - 富途牛牛
Chipmakers Recap: Is ZIMV attractive at current valuationJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Aug Rallies: What is eXoZymes Incs market position2025 Market WrapUp & Weekly Return Optimization Alerts - baoquankhu1.vn
Merger Talk: Is BlackRock Innovation and Growth Term Trust impacted by rising ratesJuly 2025 Update & Expert-Curated Trade Recommendations - baoquankhu1.vn
0.99%
3.03%
자본화:
|
볼륨(24시간):